​
​

Artelo Biosciences Ownership | Who Owns Artelo Biosciences?

OverviewChart

Artelo Biosciences Ownership Summary

Artelo Biosciences is owned by 3.26% institutional investors, and 96.74% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.33% of its assets in Artelo Biosciences shares.

ARTL Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockArtelo Biosciences3.26%-96.74%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202211-26.67%1,383,628-5.65%327.12%5-44.44%2-50.00%
Mar 31, 202215-6.25%1,466,422-21.68%39.16%912.50%4-
Dec 31, 20211614.29%1,872,284-5.76%65.44%814.29%4-20.00%
Sep 30, 202114-12.50%1,986,685-28.32%107.40%7-22.22%525.00%
Jun 30, 20211633.33%2,771,440108.39%1119.56%9-10.00%4300.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index10.64K0.33%-9.69K
NT Ext Equity Mkt Idx Fd - NL3.33K0.10%-
Fidelity Nasdaq Composite Index3.25K0.10%-
Fidelity Series Total Market Index3.05K0.09%-
NT Ext Equity Mkt Idx Fd - DC - NL - T22.69K0.08%8.00
Northern Trust Extended Eq Market Idx1.83K0.06%-
NT Ext Equity Mkt Idx Fd - L1.83K0.06%-
State St US Extended Mkt Indx NL Cl C693.000.02%-
SSgA U.S. Extended Market Index Class I693.000.02%-
Spartan Extended Market Index Pool E409.000.01%82.00

Recent Insider Transactions

DateNameRoleActivityValue
Aug 12, 2022Gorgas Gregory D. Pres, CEO, CFO, Treas & SecrBuy$4.80K
Aug 11, 2022Gorgas Gregory D. Pres, CEO, CFO, Treas & SecrBuy$4.84K
Apr 16, 2021Gorgas Gregory D. Pres, CEO, CFO, Treas & SecrBuy$9.81K
May 15, 2020Gorgas Gregory D. Pres, CEO, CFO, Treas & SecrBuy$10.33K
May 15, 2020Gorgas Gregory D. Pres, CEO, CFO, Treas & SecrBuy$5.07K

Insider Transactions Trends

DateBuySell
2024 Q1--
2023 Q3--
2023 Q2--
2023 Q1--
2022 Q32-

ARTL Ownership FAQ

Who Owns Artelo Biosciences?

Artelo Biosciences shareholders are primarily institutional investors at 3.26%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Artelo Biosciences's industry, Biotech Stocks , is 44.97%, which Artelo Biosciences falls below.

Does Blackrock own Artelo Biosciences?

BlackRock is not among the top 10 institutional shareholders of Artelo Biosciences.

Who is the top mutual fund holder of Artelo Biosciences shares?

Fidelity Extended Market Index is the top mutual fund holder of Artelo Biosciences shares, with 0.33% of its total shares outstanding invested in 10.64K Artelo Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools